BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35313473)

  • 1. First XEN implantation in Axenfeld- Rieger syndrome: A case report and literature review.
    Mendel L; Eremenko R; Naveh LZ; Kalev-Landoy M
    Am J Ophthalmol Case Rep; 2022 Jun; 26():101486. PubMed ID: 35313473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suprachoroidal Hemorrhage after XEN Gel Implant Requiring Surgical Drainage.
    Wang K; Wang JC; Sarrafpour S
    J Curr Glaucoma Pract; 2022; 16(2):132-135. PubMed ID: 36128082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes of Glaucoma associated with Axenfeld-Rieger syndrome.
    Zepeda EM; Branham K; Moroi SE; Bohnsack BL
    BMC Ophthalmol; 2020 May; 20(1):172. PubMed ID: 32357855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery.
    Hohberger B; Welge-Lüßen UC; Lämmer R
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):621-625. PubMed ID: 29335776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma drainage device implantation in a pregnant woman with axenfeld-rieger syndrome.
    Ramesh PV; Krishnadas SR; Senthilkumar VA; Rajasekaran R; Ramesh SV; Parthasarathi S
    Oman J Ophthalmol; 2023; 16(3):541-544. PubMed ID: 38059087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of XEN45
    Weber C; Hundertmark S; Petrak M; Ludwig E; Brinkmann CK; Holz FG; Mercieca K
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Retrospective Consecutive Study of Ab Interno XEN 45 Gel Stent Implant with Mitomycin C in Black and Afro-Latino Patients with Glaucoma: 40% Required Secondary Glaucoma Surgery at 1 Year.
    Laroche D; Nkrumah G; Ng C
    Middle East Afr J Ophthalmol; 2019; 26(4):229-234. PubMed ID: 32153335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [XEN
    Buffault J; Baudouin C; Labbé A
    J Fr Ophtalmol; 2019 Apr; 42(4):391-403. PubMed ID: 30879831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
    Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B
    Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmological Manifestations of Axenfeld-Rieger Syndrome: Current Perspectives.
    Michels K; Bohnsack BL
    Clin Ophthalmol; 2023; 17():819-828. PubMed ID: 36926528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the XEN gel implant in a patient with aniridia-associated glaucoma.
    Lindland A; Edward Michelet JT; Slagsvold JE
    Am J Ophthalmol Case Rep; 2021 Jun; 22():101080. PubMed ID: 33898859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axenfeld-Rieger syndrome combined with a foveal anomaly in a three-generation family: a case report.
    Gołaszewska K; Dub N; Saeed E; Mariak Z; Konopińska J
    BMC Ophthalmol; 2021 Mar; 21(1):154. PubMed ID: 33781219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XEN
    Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
    Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OLOGEN(®) implant in the management of glaucoma in an unusual case of Axenfeld-Rieger syndrome.
    Radhakrishnan OK; Pahuja K; Patel K; Chandna S
    Oman J Ophthalmol; 2014 May; 7(2):90-2. PubMed ID: 25136237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive High Hypermetropic Shift as a Refractive Surprise Following Glaucoma Filtration Surgery in a Phakic Child With Early-Onset Childhood Glaucoma Associated With Axenfeld-Rieger Anomaly.
    Kumar P; Senthil S
    J Glaucoma; 2019 Aug; 28(8):e136-e139. PubMed ID: 31135590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.
    Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
    Acta Ophthalmol; 2021 Jun; 99(4):e531-e539. PubMed ID: 32930515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dislocation of a previously successful XEN glaucoma implant into the anterior chamber: a case report.
    Dervenis N; Mikropoulou AM; Dervenis P; Lewis A
    BMC Ophthalmol; 2017 Aug; 17(1):148. PubMed ID: 28830369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XEN
    Buffault J; Baudouin C; Labbé A
    J Fr Ophtalmol; 2019 Feb; 42(2):e37-e46. PubMed ID: 30683533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study.
    Lenzhofer M; Kersten-Gomez I; Sheybani A; Gulamhusein H; Strohmaier C; Hohensinn M; Burkhard Dick H; Hitzl W; Eisenkopf L; Sedarous F; Ahmed II; Reitsamer HA
    Clin Exp Ophthalmol; 2019 Jul; 47(5):581-587. PubMed ID: 30578661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation.
    Lenzhofer M; Strohmaier C; Sperl P; Hohensinn M; Hitzl W; Steiner V; Moussa S; Motloch K; Baca B; Krall E; Reitsamer HA
    Acta Ophthalmol; 2019 Dec; 97(8):e1105-e1111. PubMed ID: 31210015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.